Monday, March 17, 2025

Creating liberating content

Bengaluru: A BJP legislator in Karnataka known for his outspoken

New Delhi: Orhan Awatramani, AKA Orry, has landed in legal

Related News

The state of cricketing affairs in Pakistan was already in disarray, with the men’s national team struggling to secure positive results on international cricket. And now, the losses

Bengaluru: A BJP legislator in Karnataka known for his outspoken comments has set off a new controversy with vulgar remarks about Ranya Rao, the Kannada actor facing a gold smuggling

New Delhi: Orhan Awatramani, AKA Orry, has landed in legal trouble after allegedly consuming alcohol in a hotel located in Jammu & Kashmir’s Katra. The sacred town is located near

NEW DELHI: US director of national intelligence Tulsi Gabbard on Monday held bilateral discussions with Union defence minister Rajnath Singh, focusing on the boosting defence and security ties between the

New Delhi: Khushbu Kumari, a student from Bihar’s Danapur, has found a new hope of becoming a doctor after a video of her breaking down over gender bias at her

New Delhi: The Supreme Court on Monday set aside a National Green Tribunal order that had banned the Auroville Foundation from undertaking ‘development’ activities within its township in Puducherry. A

Trending News

Top stocks to buy (AI image) Stock market recommendations: According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting March 17, 2025) are HPCL and

MUMBAI: IndusInd Bank may have overstated its net interest income in preceding quarters, research reports by brokerage houses said. As a result, the lender will take a significant hit in

NEW DELHI: India has achieved self-sufficiency in solar module manufacturing. But the feat has rendered domestic producers of polysilicon, wafers and ingots – the building blocks for modules – vulnerable

New Delhi: India and New Zealand decided to relaunch negotiations for a free trade agreement on Saturday after a gap of 10 years, a move aimed at deepening economic ties

Mumbai: A host of global and domestic factors are expected to weigh on investors’ sentiment when Dalal Street opens for trading on Monday. The escalating global tariff war between the

NEW DELHI: India’s foreign exchange reserves recorded their sharpest weekly gain in more than three years in the week ending 7 March. The exchange surged $15.27 billion to reach $653.97

US tariff: ‘No major impact on pharma’

Word Count: 713 | Estimated Reading Time: 4 minutes


US tariff: 'No major impact on pharma'
The domestic pharma industry in India may not face significant impact from potential US tariffs on pharmaceutical exports. Indian generics, which dominate exports and are in continuous demand, could absorb additional costs. Key industry players are awaiting further details on the tariffs while engaging in bilateral talks.

NEW DELHI: The domestic pharma industry may not be significantly impacted by potential US retaliatory tariffs as most exports to the US include low-cost, price-inelastic generics that remain in constant demand.
Indian pharma exports to the US, valued nearly $10 billion, mainly include oral formulations, and any additional cost burden would likely be shared between consumers, healthcare providers, and domestic companies, analysts told TOI.
India is a major supplier to the US, providing over 45% of its generic medicines, driven by an ageing population and demand for cost-effective healthcare. Given this, no country would likely disrupt such a critical supply chain.
Pharma stocks were under pressure on Feb 19, following comments from US President Donald Trump, who signalled that the US may impose tariffs of around 25% on pharmaceutical, automobiles and semiconductor imports. The industry is in a wait-and-watch mode, awaiting clarity on the details of potential tariffs, and is hopeful that a resolution may be reached through bilateral talks.
Indian pharmaceutical industry plays a vital role in ensuring access to affordable, quality-assured medicines in the US, supplying nearly 47% of the generic medicines for American patients and contributing significantly to the country’s healthcare savings. The proposal regarding reciprocal tariffs is currently under talks and is being examined. This matter will be discussed through bilateral engagements,” Sudarshan Jain, secretary general, Indian Pharma Alliance said.
An imposition of a potential tariff would make a small difference in absolute terms for certain players, analysts feel. In some cases, widely-sold paracetamol, azithromycin, cephalosporins cost as low as 2 cents a tablet.
“The effect will be more on innovators than generics as generics are very low in value. Some of these will be passed on and some will be absorbed by the seller. We will have to wait and see the financial impact,” Sujay Shetty, global health industries advisory leader, PwC India said.
“We don’t see much of a significant impact on Indian pharma (as of now). India is a strategic partner, which meets about 45-50% of the US requirements of generic medicines,” Deepak Jotwani of Icra said.





Source link

Sign In

Welcome ! Log into Your Account